Status:
RECRUITING
Novosyn® Quick in Patients Undergoing Episiotomy Closure
Lead Sponsor:
Aesculap AG
Collaborating Sponsors:
B.Braun Surgical SA
Conditions:
Episiotomy Wound
Eligibility:
FEMALE
18+ years
Brief Summary
Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.
Detailed Description
The study design is a retrospective, consecutive series of women with a spontaneous vaginal delivery who required an indicated episiotomy with Novosyn® Quick between the period January 2020 - December...
Eligibility Criteria
Inclusion
- Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick
Exclusion
- No exclusion criteria have been set
Key Trial Info
Start Date :
May 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05233527
Start Date
May 9 2024
End Date
October 1 2026
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IDC Hospital General de Catalunya
Sant Cugat del Vallès, Catalonia, Spain, 08190